Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 4,000 shares at $45.00 ($180K) on 2025-09-26, disclosed to the SEC on 2025-09-30.
Scheduled sale ($180k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |
| CRNX | SELL | 2024-04-08 | $4.0M | — | Filing → |